BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cediranib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cediranib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

vandetanib
70 shared targets
osi
38 shared targets
brivanib
36 shared targets
canertinib
57 shared targets
raf
42 shared targets
saracatinib
36 shared targets
defosbarasertib
40 shared targets
rebastinib
52 shared targets
pazopanib
51 shared targets
motesanib
33 shared targets
Loading evidence profile...

This evidence profile for Cediranib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.